Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
2026-09-23
|
5-day change | 1st Jan Change | ||
| 23.13 CNY | 0.00% |
|
+6.05% | -12.68% |
| 08:07am | Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products | MT |
| 09-14 | Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5% | MT |
| Market Cap | 56.83B 8.47B 7.43B 6.99B 6.39B 11.94B 811B 12.02B 83.92B 32.53B 414B 31.8B 31.1B 1,341B | P/E 2026 * |
16.1x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 69.69B 10.38B 9.11B 8.57B 7.83B 14.64B 995B 14.75B 103B 39.9B 507B 39B 38.14B 1,644B | EV / Sales 2026 * |
1.64x | EV / Sales 2027 * | 1.63x |
| Free-Float |
62.7% | Yield 2026 * |
1.92% | Yield 2027 * | 2.16% |
| 1 week | +6.05% | ||
| Current month | +3.44% | ||
| 1 month | -1.83% | ||
| 3 months | +4.85% | ||
| 6 months | -6.96% | ||
| Current year | -12.68% |
| 1 week | 21.6 |  | 23.4 |
| 1 month | 21.5 | | 23.63 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 30.75 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 59.37 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 2025-06-23 |
Zhi Huang
DFI | Director of Finance/CFO | - | 2026-04-01 |
Wen Jie Zhang
PSD | President | 59 | 2023-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 1994-03-31 |
Yi Liu
BRD | Director/Board Member | 50 | 2025-12-01 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 2020-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/30/25 | Sell | Chief Executive Officer | 87,448 | 0.0041% | ||
| 5/30/25 | Sell | Executive/Senior Manager | 31,790 | 0.0015% | ||
| 5/30/25 | Sell | Chairman | 63,614 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.05% | -24.88% | -18.76% | 8.49B | |
| -1.44% | +1.75% | +55.00% | +109.63% | 1,043B | |
| -0.20% | +0.58% | +52.24% | +67.74% | 649B | |
| +0.14% | +0.96% | +19.06% | +71.37% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.54% | 355B | |
| +0.98% | +2.91% | +20.59% | +27.14% | 270B | |
| -1.91% | +2.42% | +10.41% | +11.04% | 262B | |
| -0.97% | +8.50% | +42.38% | +53.02% | 222B | |
| -0.91% | +1.83% | +31.45% | +100.96% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.41% | 175B | |
| Average | -0.64% | +2.60% | +21.06% | +40.73% | 364.15B | |
| Weighted average by Cap. | -0.67% | +2.20% | +35.97% | +65.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.53B 6.34B 5.56B 5.23B 4.78B 8.93B 607B 9B 62.8B 24.35B 309B 23.8B 23.28B 1,003B | 43.27B 6.45B 5.66B 5.32B 4.86B 9.09B 618B 9.16B 63.9B 24.77B 315B 24.21B 23.68B 1,021B |
| Net income | 3.83B 570M 500M 470M 430M 803M 54.6B 809M 5.65B 2.19B 27.84B 2.14B 2.09B 90.26B | 4.24B 632M 554M 521M 476M 890M 60.49B 897M 6.26B 2.43B 30.84B 2.37B 2.32B 100B |
| Net Debt | 12.86B 1.92B 1.68B 1.58B 1.45B 2.7B 184B 2.72B 18.99B 7.36B 93.6B 7.2B 7.04B 303B | 14.06B 2.1B 1.84B 1.73B 1.58B 2.95B 201B 2.98B 20.77B 8.05B 102B 7.87B 7.7B 332B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | CN¥23.13 | 0.00% | 18,292,540 |
| 26-09-22 | CN¥23.13 | +0.35% | 31,382,496 |
| 26-09-21 | CN¥23.05 | +4.63% | 35,026,290 |
| 26-09-18 | CN¥22.03 | +1.15% | 14,394,191 |
| 26-09-17 | CN¥21.78 | +0.09% | 8,902,897 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Select your edition
All financial news and data tailored to specific country editions
